- Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease.
[作者：Hsieh, MM; Kang, EM; Fitzhugh, CD; Link, MB; Bolan, CD; Kurlander, R; Childs, RW; Rodgers, GP; Powell, JD; Tisdale, JF,期刊：New England Journal of Medicine, 页码：2309-2317 , 文章类型： Article，,卷期：2009年361-24]
- Background: Myeloablative allogeneic hematopoietic stem-cell transplantation is curative in children with sickle cell disease, but in adults the procedure is unduly toxic. Graft rejection and graft-versus-host disease (G...
- Platelet Inhibition with Cangrelor in Patients Undergoing PCI.
[作者：Harrington, RA; Stone, GW; McNulty, S; White, HD; Lincoff, AM; Gibson, CM; Pollack, CV; Montalescot, G; Mahaffey, KW; Kleiman, NS; Goodman, SG; Amine, M; Angiolillo, DJ; Becker, RC; Chew, DP; French, WJ; Leisch, F; Parikh, KH; Skerjanec, S; Bhatt, DL,期刊：New England Journal of Medicine, 页码：2318-2329 , 文章类型： Article，,卷期：2009年361-24]
- Background: Cangrelor, a nonthienopyridine adenosine triphosphate analogue, is an intravenous blocker of the adenosine diphosphate receptor P2Y(sub 12). This agent might have a role in the treatment of patients who requi...
- Intravenous Platelet Blockade with Cangrelor during PCI.
[作者：Bhatt, DL; Lincoff, AM; Gibson, CM; Stone, GW; McNulty, S; Montalescot, G; Kleiman, NS; Goodman, SG; White, HD; Mahaffey, KW; Pollack, CV; Manoukian, SV; Widimsky, P; Chew, DP; Cura, F; Manukov, I; Tousek, F; Jafar, MZ; Arneja, J; Skerjanec, S; Harrington, RA,期刊：New England Journal of Medicine, 页码：2330-2341 , 文章类型： Article，,卷期：2009年361-24]
- Background: Intravenous cangrelor, a rapid-acting, reversible adenosine diphosphate (ADP) receptor antagonist, might reduce ischemic events during percutaneous coronary intervention (PCI).Methods: In this double-blind, p...
- cA Boy with Paroxysmal Headaches and Visual Changes Spinal arachnoid cyst.
[作者：Brass, SD; Dinkin, MJ; Williams, Z; Krishnamoorthy, KS; Copen, WA; Freeman, SH,期刊：New England Journal of Medicine, 页码：2367-2378 , 文章类型： Article，,卷期：2009年361-24]
-
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism.
[作者：Schulman, S; Kearon, C; Kakkar, AK; Mismetti, P; Schellong, S; Eriksson, H; Baanstra, D; Schnee, J; Goldhaber, SZ,期刊：New England Journal of Medicine, 页码：2342-2352 , 文章类型： Article，,卷期：2009年361-24]
- Background: The direct oral thrombin inhibitor dabigatran has a predictable anticoagulant effect and may be an alternative therapy to warfarin for patients who have acute venous thromboembolism.Methods: In a randomized, ...
|